Drug Research

Charles River Laboratories International, Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced a viral vector contract development and manufacturing organization (CDMO) partnership. Rznomics will leverage Charles River’s viral vector...

Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), said that the European Medicines Agency (EMA) has granted priority medicines (PRIME) designation to FBX-101, Forge’s lead adeno-associated virus (AAV) drug candidate and novel gene therapy for treating...

To host the Microbiome Summit 2023 at the Hong Kong Science Park, the medicine faculty of the Chinese University of Hong Kong, Hong Kong Science and Technology Parks Corporation and Microbiota I-Center joined hands recently. More than 20 eminent...

A senior Biden White House official said on January 11 that the U.S. administration will provide a list of the ten prescription pharmaceuticals for which it intends to negotiate prices on September 1 and the costs a year later. The...

According to Stella Kyriakides, the EU Health Commissioner, the thought about changes to EU pharmaceutical law shall have robust obligations for medicine supply and also earlier shortage notifications. She was speaking at the European Parliament session, where she opined that...

The FDA's Final Guidance on REMS programmes for prescription medications, has just been published. The document is officially titled Format and Content of a REMS Document: Guidance for Industry. The FDA may demand a risk management strategy known as REMS,...

The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good Manufacturing Practices (GMP). The US Food and Drug Administration (FDA) and the Swiss Agency for Therapeutic Products (Swissmedic) will be able to utilize each other's...